Human Leukocyte Antigen – DR isotype''

Human Leukocyte Antigen – DR isotype''

HLA-DR is an MHC class II cell surface receptor
Featured Image

Distinctive germline expression of class I human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade

Background: Nivolumab is a human monoclonal antibody against programmed cell death receptor-1 (PD-1) capable of tumor rescue secretly infiltrating cytotoxic T lymphocytes (CTL) to recover their ability to kill target cells expressing the peptide epitopes specific tumor antigens derived bound homologous human leukocyte antigen (HLA) molecules. Nivolumab currently active therapeutic agents but expensive for metastatic non-small cell lung cancer (mNSCLC), producing, in some cases, the immune-related adverse events (irAEs). Currently, there are no reliable biomarkers have been validated to predict either treatment response or adverse events in patients treated.


Methods: We conducted a multi-institutional retrospective analysis included 119 patients with mNSCLC who receive PD-1 blockade since November 2015 to investigate the predictive role of germinal class I HLA and DRB1 genotypes. We investigated the correlation between patient outcomes and the frequency irAEs with specific HLA A, B, C, and DRB1 alleles with a specific sequence of DNA typing reverse oligonucleotide (SSO).


Results: A poor outcome in patients negative for expression of the two alleles of HLA-A is the most frequently detected (HLA: HLA-A * 01 or A * 02; progression-free survival (PFS): 7,5 (2,8- 12.2) vs 15.9 (0 to 39.2) months, p = 0.01).

In particular, patients with HLA-A * 01-positive indicates a prolonged PFS of 22.6 (10.2 to 35.0) and overall survival (OS) of 30.8 (7.7 to 53.9) months, respectively -masing. We also reported that the HLA-A and DRB1 locus heterozygosis (het) were correlated with OS het bad if we considered the locus of A; inversely, correlated with the length of survival in DRB1 het.


Conclusion: This study shows that class I and II HLA alleles characterization to determine the immunogenicity of tumors have relevant implications in predicting success in mNSCLC nivolumab and give reason for further prospective trials of cancer immunotherapy.

Distinctive germline expression of class I human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade
Distinctive germline expression of class I human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade

Class I Human Leukocyte Antigen Detection and Response to Platelet Transfusion Patients Undergoing Liver Transplantation

Background: Patients undergoing liver transplantation (LT) often receive transfusions of platelets (PLT) to minimize the risk of bleeding. Alloimmunization for platelets can cause refractoriness to PLT. Data on the implications of platelet alloimmunization in patients undergoing LT remains limited. We investigated the effect of human leukocyte antigen class I (HLA-I) antibody in PLT refractoriness and short-term outcomes after LT.


Methods: The clinical factors and PLT Peritransplant reviewed for all adult liver transplantation or simultaneous liver-kidney patients from 2012 to 2017. Sensitive (SE) with HLA-I calculated pretransplant panel-reactive antibody ≥20% compared to patients not sensitized (USA) with calculated panel-reactive antibodies <20%. Mean follow-up was 21.4 mo.


Results: alloimmunization observed in 39% of the study group. SE (n = 28) received 272 PLTS, and the US (n = 44) received 246 solar. History of pregnancy was higher in the SE of the US (P <0.01); if not, both groups had similar clinical characteristics. SE has a higher level of PLT refractory (66% versus 47%; P <0.01) from the US.

Mean platelet count corrected lower rise in the SE compared to the US until 100 minutes after the PLT (P <0.05). Alloimmunization and simultaneous liver-kidney transplants independently predicted refractory multivariate logistic regression (P <0.05). rejection and patient survival rate of early allograft comparable for both groups.

HLA-DR+DP Antibody (Biotin)

abx140300-01mg 0.1 mg
EUR 425

anti-HLA-DR

YF-PA12351 50 ug
EUR 363
Description: Mouse polyclonal to HLA-DR

anti-HLA-DR

YF-PA12352 50 ul
EUR 363
Description: Mouse polyclonal to HLA-DR

anti-HLA-DR

YF-PA12353 50 ug
EUR 363
Description: Mouse polyclonal to HLA-DR

anti-HLA-DR

YF-PA12354 100 ul
EUR 403
Description: Rabbit polyclonal to HLA-DR

anti-HLA-DR

YF-PA12355 100 ug
EUR 403
Description: Rabbit polyclonal to HLA-DR

anti-HLA-DR

520-A-01mg 0,1 mg
EUR 267.5
Description: anti-HLA-DR

anti-HLA-DR

520-A-1000ug 1000 ug
EUR 1282.5
Description: anti-HLA-DR

Anti-HLA/DR antibody

STJ16100046 100 µg
EUR 406

Anti-HLA-DR/HLA-DRA Antibody

A01195 100ug/vial
EUR 334

Anti-HLA-DR Purified

11-241-C025 0.025 mg
EUR 104

Anti-HLA-DR Purified

11-241-C100 0.1 mg
EUR 167

Anti-HLA-DR Purified

11-474-C025 0.025 mg
EUR 104

Anti-HLA-DR Purified

11-474-C100 0.1 mg
EUR 167

Anti-HLA-DR Purified

11-690-C025 0.025 mg
EUR 104

Anti-HLA-DR Purified

11-690-C100 0.1 mg
EUR 167

Anti-HLA-DR APC

1A-474-T025 25 tests
EUR 140

Anti-HLA-DR APC

1A-474-T100 100 tests
EUR 240

Anti-HLA-DR APC

1A-690-T025 25 tests
EUR 140

Anti-HLA-DR APC

1A-690-T100 100 tests
EUR 240

Anti-HLA-DR FITC

1F-474-T025 25 tests
EUR 122

Anti-HLA-DR FITC

1F-474-T100 100 tests
EUR 204

Anti-HLA-DR FITC

1F-690-T025 25 tests
EUR 122

Anti-HLA-DR FITC

1F-690-T100 100 tests
EUR 204

Anti-HLA-DR PE

1P-474-T025 25 tests
EUR 140

Anti-HLA-DR PE

1P-474-T100 100 tests
EUR 240

Anti-HLA-DR PE

1P-690-T025 25 tests
EUR 140

Anti-HLA-DR PE

1P-690-T100 100 tests
EUR 240

Anti-HLA-DR PerCP

PC-474-T025 25 tests
EUR 140

Anti-HLA-DR PerCP

PC-474-T100 100 tests
EUR 240

Anti-HLA-DR+DP antibody

STJ16100003 100 µg
EUR 406

Anti-HLA-DR antigen antibody

STJ16100045 1 mL
EUR 478

Anti-HLA-DR+DP antibody

STJ16100047 100 µg
EUR 406

Anti-HLA-DR+DP antibody

STJ16100576 100 tests
EUR 524

HLA-DR

HLADRA-100T 100 test
EUR 411.4

HLA-DR

HLADRAC750-100T 100 test
EUR 583

HLA-DR

HLADRB-01MG 100 test
EUR 284

HLA-DR

HLADRCFB-100T 100 test
EUR 388

HLA-DR

HLADRCFB2-100T 100 test
EUR 388

HLA-DR

HLADRF-100T 100 test
EUR 297

HLA-DR

HLADRPE-100T 100 test
EUR 349

HLA-DR

HLADRPP-100T 100 test
EUR 349

HLA-DR

HLADRPP5.5-100T 100 test
EUR 388

HLA-DR

HLADRPP5.52-100T 100 test
EUR 531

HLA-DR

HLADRPU-01MG 0,1 mg
EUR 219

HLA-DR antibody

23013-100ul 100ul
EUR 390

HLA-DR Antibody

48982-100ul 100ul
EUR 333

HLA-DR Antibody

48982-50ul 50ul
EUR 239

Anti-HLA-DRA/Hla Dr Rabbit Monoclonal Antibody

M01195-2 100ug/vial
EUR 397
Description: Rabbit Monoclonal HLA-DRA/Hla Dr Antibody. Validated in IF, WB and tested in Human, Mouse, Rat.

Mouse Anti Human Hla Dr Monoclonal Antibody

DMABT-48801MH 0.2 mg
EUR 881

Mouse Anti Human Hla Dr Monoclonal Antibody

DMABT-48806MH 0.2 mg
EUR 767

Rat Anti Human Hla Dr Monoclonal Antibody

DMABT-48809RH 0.25 mg
EUR 767

Rat Anti Human Hla Dr Monoclonal Antibody

DMABT-48811RH 5 ml
EUR 580

HLA-DR Antigens-Associated Invariant Chain (HLA-DR) Antibody

abx413474-02mg 0.2 mg
EUR 565

HLA-DR Antigens-Associated Invariant Chain (HLA-DR) Antibody

abx415437-025mg 0.25 mg
EUR 565

HLA-DR Antigens-Associated Invariant Chain (HLA-DR) Antibody

abx415449-02mg 0.2 mg
EUR 565

HLA-DR Antigens-Associated Invariant Chain (HLA-DR) Antibody

abx200524-100ug 100 ug
EUR 328

HLA-DR Antigens-Associated Invariant Chain (HLA-DR) Antibody

abx140253-01mg 0.1 mg
EUR 370

HLA-DR Antigens-Associated Invariant Chain (HLA-DR) Antibody

abx140231-01mg 0.1 mg
EUR 370

HLA-DR Antigens-Associated Invariant Chain (HLA-DR) Antibody

abx140254-01mg 0.1 mg
EUR 370

HLA-DR Antigens-Associated Invariant Chain (HLA-DR) Antibody

abx140257-01mg 0.1 mg
EUR 370

Anti-HLA-DR/DP Purified

11-239-C025 0.025 mg
EUR 99

Anti-HLA-DR/DP Purified

11-239-C100 0.1 mg
EUR 158

Anti-HLA-DR/DP Purified

11-240-C025 0.025 mg
EUR 99

Anti-HLA-DR/DP Purified

11-240-C100 0.1 mg
EUR 158

Anti-HLA-DR/DP Purified

11-296-C025 0.025 mg
EUR 99

Anti-HLA-DR/DP Purified

11-296-C100 0.1 mg
EUR 158

Anti-HLA-DR/DP APC

1A-296-T025 25 tests
EUR 140

Anti-HLA-DR/DP APC

1A-296-T100 100 tests
EUR 240

Anti-HLA-DR/DP FITC

1F-239-T025 25 tests
EUR 122

Anti-HLA-DR/DP FITC

1F-239-T100 100 tests
EUR 204

Anti-HLA-DR/DP FITC

1F-296-T025 25 tests
EUR 122

Anti-HLA-DR/DP FITC

1F-296-T100 100 tests
EUR 204

Anti-HLA-DR/DP PE

1P-239-T025 25 tests
EUR 140

Anti-HLA-DR/DP PE

1P-239-T100 100 tests
EUR 240

Anti-HLA-DR/DP PE

1P-296-T025 25 tests
EUR 140

Anti-HLA-DR/DP PE

1P-296-T100 100 tests
EUR 240

Anti-HLA-DR Alexa Fluor647

A6-690-T025 25 tests
EUR 154

Anti-HLA-DR Alexa Fluor647

A6-690-T100 100 tests
EUR 269

Anti-HLA-DR Alexa Fluor700

A7-474-T025 25 tests
EUR 154

Anti-HLA-DR Alexa Fluor700

A7-474-T100 100 tests
EUR 269

Anti-HLA-DR APC-Cy7

T4-690-T025 25 tests
EUR 154

Anti-HLA-DR APC-Cy7

T4-690-T100 100 tests
EUR 268

Anti-HLA-DR PE-DyLight594

T5-690-T025 25 tests
EUR 154

Anti-HLA-DR PE-DyLight594

T5-690-T100 100 tests
EUR 268

Anti-HLA-DR PE-Cy7

T7-690-T025 25 tests
EUR 154

Anti-HLA-DR PE-Cy7

T7-690-T100 100 tests
EUR 268

Anti-HLA-DR PE-Cy5

T8-690-T025 25 tests
EUR 140

Anti-HLA-DR PE-Cy5

T8-690-T100 100 tests
EUR 240

Anti-HLA-DR PerCP-Cy5.5

T9-690-T025 25 tests
EUR 196

Anti-HLA-DR PerCP-Cy5.5

T9-690-T100 100 tests
EUR 352

Anti-HLA-DR Pacific Blue

PB-474-T025 25 tests
EUR 154

Anti-HLA-DR Pacific Blue

PB-474-T100 100 tests
EUR 269

Anti-HLA-DR Pacific Blue

PB-690-T025 25 tests
EUR 154

Anti-HLA-DR Pacific Blue

PB-690-T100 100 tests
EUR 269

Anti-HLA-DR Pacific Orange

PO-690-T025 25 tests
EUR 154

Anti-HLA-DR Pacific Orange

PO-690-T100 100 tests
EUR 269

HLA-DR Antibody (FITC)

abx200525-100tests 100 tests
EUR 398

HLA-DR Antibody (FITC)

abx134336-100Assays 100 Assays
EUR 439

HLA-DR Antibody (FITC)

abx134336-50Assays 50 Assays
EUR 342

HLA-DR+DP Antibody

abx140228-01mg 0.1 mg
EUR 356

HLA-DR+DP Antibody

abx140232-01mg 0.1 mg
EUR 356

HLA-DR+DP Antibody

abx140233-01mg 0.1 mg
EUR 356

HLA-DR Antibody (FITC)

abx140296-100tests 100 tests
EUR 425

HLA-DR Antibody (FITC)

abx140304-100tests 100 tests
EUR 425

HLA DR beta antibody

23015-100ul 100ul
EUR 390

HLA-DR Conjugated Antibody

C48982 100ul
EUR 397

HLA-DR/CD34

HLADRF34PE-50T 50 test
EUR 323

HLA-DR/CD3

HLADRF3PE1-50T 50 test
EUR 350.3

HLA-DR/CD8

HLADRF8PE1-50T 50 test
EUR 350.3

HLA-DR Antigens-Associated Invariant Chain (HLA-DR) Antibody (RPE)

abx413475-100tests 100 tests
EUR 592

HLA-DR Antigens-Associated Invariant Chain (HLA-DR) Antibody (FITC)

abx415435-01mg 0.1 mg
EUR 509

HLA-DR Antigens-Associated Invariant Chain (HLA-DR) Antibody (RPE)

abx415436-100tests 100 tests
EUR 592

HLA-DR Antigens-Associated Invariant Chain (HLA-DR) Antibody (PE)

abx200526-100tests 100 tests
EUR 453

HLA-DR Antigens-Associated Invariant Chain (HLA-DR) Antibody (APC)

abx200527-100tests 100 tests
EUR 634

HLA-DR Antigens-Associated Invariant Chain (HLA-DR) Antibody (PerCP)

abx200528-100tests 100 tests
EUR 453

HLA-DR Antigens-Associated Invariant Chain (HLA-DR) Antibody (PerCP)

abx140293-100tests 100 tests
EUR 481

HLA-DR Antigens-Associated Invariant Chain (HLA-DR) Antibody (PE)

abx140305-100tests 100 tests
EUR 481

HLA-DR Antigens-Associated Invariant Chain (HLA-DR) Antibody (PE)

abx140294-100tests 100 tests
EUR 481

HLA-DR Antigens-Associated Invariant Chain (HLA-DR) Antibody (APC)

abx140295-100tests 100 tests
EUR 481

HLA-DR Antigens-Associated Invariant Chain (HLA-DR) Antibody (APC)

abx140306-100tests 100 tests
EUR 481

Anti-human CD14 Monoclonal Antibody Biotin Conjugated, Flow Validated

FC00137-Biotin 100µg
EUR 233
Description: Mouse Monoclonal human CD14 Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD11b Monoclonal Antibody Biotin Conjugated, Flow Validated

FC00144-Biotin 100µg
EUR 152
Description: Mouse Monoclonal human CD11b Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD19 Monoclonal Antibody Biotin Conjugated, Flow Validated

FC00154-Biotin 100µg
EUR 152
Description: Mouse Monoclonal human CD19 Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD38 Monoclonal Antibody Biotin Conjugated, Flow Validated

FC00193-Biotin 100µg
EUR 152
Description: Mouse Monoclonal human CD38 Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD25 Monoclonal Antibody Biotin Conjugated, Flow Validated

FC00214-Biotin 100µg
EUR 233
Description: Mouse Monoclonal human CD25 Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD4 Monoclonal Antibody Biotin Conjugated, Flow Validated

FC00344-Biotin 100µg
EUR 152
Description: Mouse Monoclonal human CD4 Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD5 Monoclonal Antibody Biotin Conjugated, Flow Validated

FC00480-Biotin 100µg
EUR 233
Description: Mouse Monoclonal human CD5 Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD45 Monoclonal Antibody Biotin Conjugated, Flow Validated

FC00555-Biotin 100µg
EUR 152
Description: Mouse Monoclonal human CD45 Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD2 Monoclonal Antibody Biotin Conjugated, Flow Validated

FC00570-Biotin 100µg
EUR 233
Description: Mouse Monoclonal human CD2 Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD71 Monoclonal Antibody Biotin Conjugated, Flow Validated

FC00591-Biotin 100µg
EUR 245
Description: Mouse Monoclonal human CD71 Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD62L Monoclonal Antibody Biotin Conjugated, Flow Validated

FC00652-Biotin 100µg
EUR 233
Description: Mouse Monoclonal human CD62L Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD59 Monoclonal Antibody Biotin Conjugated, Flow Validated

FC00914-Biotin 100µg
EUR 265
Description: Mouse Monoclonal human CD59 Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD117 Monoclonal Antibody Biotin Conjugated, Flow Validated

FC01335-Biotin 100μg
EUR 224
Description: Mouse Monoclonal human CD117 Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD32 Monoclonal Antibody Biotin Conjugated, Flow Validated

FC01450-Biotin 100µg
EUR 233
Description: Mouse Monoclonal human CD32 Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD90 Monoclonal Antibody Biotin Conjugated, Flow Validated

FC01818-Biotin 100µg
EUR 268
Description: Mouse Monoclonal human CD90 Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD7 Monoclonal Antibody Biotin Conjugated, Flow Validated

FC01974-Biotin 100µg
EUR 233
Description: Mouse Monoclonal human CD7 Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD235a Monoclonal Antibody Biotin Conjugated, Flow Validated

FC02184-Biotin 100µg
EUR 245
Description: Mouse Monoclonal human CD235a Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD8 Monoclonal Antibody Biotin Conjugated, Flow Validated

FC02236-Biotin 100µg
EUR 152
Description: Mouse Monoclonal human CD8 Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-Human VEGI Monoclonal Antibody Biotin Conjugated, Flow Validated

FC02402-Biotin Various Sizes
EUR 497
Description: Mouse Monoclonal Human VEGI Antibody Biotin Conjugated, Flow Validated. Validated in WB and tested in Human.

Anti-human CD3 Monoclonal Antibody Biotin Conjugated, Flow Validated

FC02675-Biotin 100µg
EUR 152
Description: Mouse Monoclonal human CD3 Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD20 Monoclonal Antibody Biotin Conjugated, Flow Validated

FC03780-Biotin 100µg
EUR 233
Description: Mouse Monoclonal human CD20 Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD10 Monoclonal Antibody Biotin Conjugated, Flow Validated

FC04065-Biotin 100µg
EUR 189
Description: Mouse Monoclonal human CD10 Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD57 Monoclonal Antibody Biotin Conjugated, Flow Validated

FC09548-Biotin 100µg
EUR 245
Description: Mouse Monoclonal human CD57 Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Mouse Anti Human Hla Dr Monoclonal Antibody,APC

DMABT-48803MH 100 TEST
EUR 767

Mouse Anti Human Hla Dr Monoclonal Antibody,RPE

DMABT-48807MH 100 TEST
EUR 715

Rat Anti Human Hla Dr Monoclonal Antibody,FITC

DMABT-48808RH 0.1 mg
EUR 663

Rat Anti Human Hla Dr Monoclonal Antibody,RPE

DMABT-48810RH 100 TEST
EUR 710

Anti-HLA-DR Antibody [L243], PerCP-100Tests

QAB86-PCP-100Tests 100Tests
EUR 428

Anti-HLA-DR Antibody [L243], PerCP-25Tests

QAB86-PCP-25Tests 25Tests
EUR 225

Anti-HLA-DR Antibody [L243], PE-100Tests

QAB86-PE-100Tests 100Tests
EUR 251

Anti-HLA-DR Antibody [L243], PE-25Tests

QAB86-PE-25Tests 25Tests
EUR 141

Anti-HLA-DR Antibody [L243], PE-500Tests

QAB86-PE-500Tests 500Tests
EUR 893

Anti-HLA-DR Purified Low Endotoxin

12-690-C100 0.1 mg
EUR 167

Anti-HLA-DR/DP Alexa Fluor700

A7-296-T025 25 tests
EUR 154

Anti-HLA-DR/DP Alexa Fluor700

A7-296-T100 100 tests
EUR 269

Anti-HLA-DR/DP Pacific Blue

PB-296-T025 25 tests
EUR 154

Anti-HLA-DR/DP Pacific Blue

PB-296-T100 100 tests
EUR 269

Anti-human CD55/Daf Monoclonal Antibody Biotin Conjugated, Flow Validated

FC00910-Biotin 100µg
EUR 233
Description: Mouse Monoclonal human CD55/Daf Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

HLA-DR Antigens-Associated Invariant Chain (HLA-DR) Antibody (CF-Blue)

abx200530-100tests 100 tests
EUR 481

HLA-DR Antigens-Associated Invariant Chain (HLA-DR) Antibody (OC-515)

abx200531-100tests 100 tests
EUR 467

HLA-DR Antigens-Associated Invariant Chain (HLA-DR) Antibody (APC-C750)

abx200532-100tests 100 tests
EUR 996

HLA-DR Antigens-Associated Invariant Chain (HLA-DR) Antibody (PerCP-Cy5.5)

abx200533-100tests 100 tests
EUR 481

HLA-DR Antigens-Associated Invariant Chain (HLA-DR) Antibody (CF-Blue)

abx200534-100tests 100 tests
EUR 481

HLA-DR Antigens-Associated Invariant Chain (HLA-DR) Antibody (PerCP-Cy5.5)

abx200535-100tests 100 tests
EUR 773

HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DR) Antibody

20-abx134338
  • EUR 356.00
  • EUR 565.00
  • EUR 300.00
  • 100 ul
  • 200 ul
  • 50 ul

Anti-human CD33/Siglec 3 Monoclonal Antibody Biotin Conjugated, Flow Validated

FC01508-Biotin 100µg
EUR 234
Description: Mouse Monoclonal human CD33/Siglec 3 Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD22/Siglec 2 Monoclonal Antibody Biotin Conjugated, Flow Validated

FC01572-Biotin 100µg
EUR 233
Description: Mouse Monoclonal human CD22/Siglec 2 Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

HLA-DR+DP Antibody (PE)

abx140298-100tests 100 tests
EUR 481

HLA-DR+DP Antibody (FITC)

abx140301-100tests 100 tests
EUR 425

HLA-DR+DP Antibody (FITC)

abx140302-100tests 100 tests
EUR 425

HLA-DR+DP Antibody (PE)

abx140297-100tests 100 tests
EUR 481

HLA-DR+DP Antibody (APC)

abx140299-100tests 100 tests
EUR 481

Anti-human HLA-DR Monoclonal Antibody Unconjugated, Flow Validated

FC00568 100µg, 500µg
EUR 114
Description: Mouse Monoclonal human HLA-DR Antibody Unconjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Mouse Anti Human Hla Dp Dq Dr Monoclonal Antibody

DMABT-48793MH 0.2 mg
EUR 741

Mouse Anti Human Hla Dp Dq Dr Monoclonal Antibody

DMABT-48795MH 0.2 mg
EUR 767

Mouse Anti Human Hla Dr Monoclonal Antibody,Azide Free

DMABT-48804MH 1 mg
EUR 1261

HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DR) Antibody (PE)

abx134337-100Assays 100 Assays
EUR 495

HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DR) Antibody (PE)

abx134337-50Assays 50 Assays
EUR 398

HLA-DR Antigens-Associated Invariant Chain (HLA-DR) Antibody (PE-DyLight 594)

abx140339-100tests 100 tests
EUR 523

Anti-HLA-DR Antibody [L243], APC-Cy7-100Tests

QAB86-APC7-100Tests 100Tests
EUR 403

Anti-HLA-DR Antibody [L243], APC-Cy7-25Tests

QAB86-APC7-25Tests 25Tests
EUR 225

Anti-HLA-DR Antibody [L243], Qfluor 710-100Tests

QAB86-QF710-100Tests 100Tests
EUR 352

Anti-HLA-DR Antibody [L243], Qfluor 710-25Tests

QAB86-QF710-25Tests 25Tests
EUR 200


Conclusions: LT patients experiencing high levels of HLA-I and PLT refractory alloimmunization. SE has a higher level of the refractory and the average increase in the number of corrected lower after transfusion compared with the US. Our study suggests that further studies to evaluate the utility SPP HLA-matched at HLA-I alloimmunized LT patients is warranted.